Relevant bibliographies by topics / MS – Multiple Sclerosis

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'MS – Multiple Sclerosis'

Author: Grafiati
Published: 3 June 2025
Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'MS – Multiple Sclerosis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "MS – Multiple Sclerosis"

1

Mazziotti, Valentina. "Pregnancy in Multiple Sclerosis." Archives of Case Reports: Open Access 1, no. 1 (2024): 01–04. http://dx.doi.org/10.33140/acroa.01.01.01.

Full text
Abstract:
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that affects 2.3 million people worldwide, mostly young adults, with a high female prevalence (70% to 75%). Therefore, most individuals who get diagnosed with MS are women of childbearing age. However, disease activity is greatly reduced during the last trimester of pregnancy, although an increased relapse rate is observed in the three months after delivery. Despite several studies point to pregnancy as a period of stabilization in the clinical course of MS, pregnancy in MS remains a controversial iss
APA, Harvard, Vancouver, ISO, and other styles
2

Artur Medina, Jose. "Multiple Sclerosis and Chlamydia." International Journal of Clinical Case Reports and Reviews 9, no. 1 (2021): 01–02. http://dx.doi.org/10.31579/2690-4861/163.

Full text
Abstract:
Although the epidemiological similarity between the two diseases is true, this thesis was not discussed extensively, perhaps because it implied that some children might have been victims of abuse, which sounds false and potentially unfair. We believe that transverse myelitis and MS are the result of an infectious disease, eventually sexually transmitted by chlamydia/gonococcus, which is caused by a subclinical bacterial urethritis/inflamatory pelvic disease (IPD) among adults. In children it is the same disease but caused by common uropathogens/enterobacteria. Both UTI and MS are much more com
APA, Harvard, Vancouver, ISO, and other styles
3

S, P. SRINIVAS NAYAK, Tabassum Javeriya, and Naaz Mahjabeen. "Management of Multiple Sclerosis and Effectiveness of Ozanimod in Relapsing Multiple Sclerosis." Management of Multiple Sclerosis and Effectiveness of Ozanimod in Relapsing Multiple Sclerosis 3, no. 6 (2020): 67–73. https://doi.org/10.5281/zenodo.5469941.

Full text
Abstract:
Multiple Sclerosis (MS) is termed as an autoimmune disorder characterised by multiple demyelinating lesions in the central nervous system (CNS). Till date, no drug provides the complete cure for MS. All the immunotherapeutic agents and most of the receptor modulators target Relapsing Multiple Sclerosis (RMS). Thus the main challenge until recent times remained to develop a suitable therapy for Secondary progressive MS (SPMS), until the approval of the non-selective sphingosine-1-phosphate (S1P) receptor modulator Fingolimod in 2010 which led to the discovery of many such drugs over the years.
APA, Harvard, Vancouver, ISO, and other styles
4

eyedaghanoor, Sadegh. "How to Heal Patient with Multiple Sclerosis." Journal of Biomedical Research & Environmental Sciences 2, no. 6 (2021): 523–24. https://doi.org/10.37871/jbres1269.

Full text
Abstract:
Multiple Sclerosis (MS) has been defined as an inflammatory demyelinating condition afflicting more than 2.8 million people worldwide. Meta-regression analyses of studies on MS epidemiology since 1965 revealed an almost universal increase in prevalence and incidence of MS over time; and suggest a general increase in incidence of MS in females. The study for prevalence estimation of MS in Iran in 2013 indicated a high prevalence rate in Isfahan (89 per 100000 of population) and Tehran (88/100000), situated at the central part of Iran (5). Numerous studies revealed that having positive family hi
APA, Harvard, Vancouver, ISO, and other styles
5

Budimkić, Maja, Olivera Tamaš, Nikola Veselinović, Šarlota Mesaroš, and Jelena Drulović. "Late onset multiple sclerosis." Medicinski podmladak 75, no. 5 (2024): 48–57. https://doi.org/10.5937/mp75-52391.

Full text
Abstract:
Multiple sclerosis (MS) is an inflammatory demyelinating and neurodegenerative disease of the central nervous system (CNS) that usually occurs between the ages of 20 and 40. Less often, the diagnosis of MS can be made in children and adolescents, before the age of 18, as well as in people aged 50 and over. If the symptoms of MS appear in people aged 50 and over, this form of the disease is called late onset MS (LOMS). Compared to the classic onset of MS, people with LOMS are characterized by a more frequent occurrence of a progressive course of the disease, a delay in establishing a diagnosis
APA, Harvard, Vancouver, ISO, and other styles
6

Rohani, Mohammad, and Shadi Ghourchian. "Fulminant multiple sclerosis (MS)." Neurological Sciences 32, no. 5 (2011): 953–57. http://dx.doi.org/10.1007/s10072-011-0723-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Alroughani, Raed, and Bassem Yamout. "Multiple Sclerosis." Seminars in Neurology 38, no. 02 (2018): 212–25. http://dx.doi.org/10.1055/s-0038-1649502.

Full text
Abstract:
AbstractMultiple sclerosis (MS) is a chronic central nervous system inflammatory disease of autoimmune etiology, mediated by activated T cells with evolving evidence of a significant contribution from B cells and cells of the innate immune system. The disease is thought to be due to a complex interaction between different genetic and environmental factors. The prevalence of MS is rising all over the world, due on one hand to earlier diagnosis and prolonged survival, and on the other to a true increase in incidence of the disease. The diagnosis of MS remains clinical despite recent advances in
APA, Harvard, Vancouver, ISO, and other styles
8

Eric, Theodore, and Bates Archer. "Multiple Sclerosis: A Systemic Review of Drugs and Therapeutics." Neuroscience and Neurological Surgery 1, no. 3 (2017): 01–03. http://dx.doi.org/10.31579/2578-8868/018.

Full text
Abstract:
Multiple sclerosis (MS) is a chronic inflammatory autoimmune demyelinating disease of the central nervous system. It affects approximately 400,000 people in the United States and onset is usually during young adulthood. There are four clinical forms of MS, of which relapsing remitting type is the most common. As the etiology of MS is unknown, finding a cure will remain challenging. The main mechanism of injury appears to be inflammation and 8 agents are now FDA approved to help control MS. These agents for relapsing forms of MS target different parts of the immune system, with the end goal of
APA, Harvard, Vancouver, ISO, and other styles
9

Canto, Ester, and Jorge R. Oksenberg. "Multiple sclerosis genetics." Multiple Sclerosis Journal 24, no. 1 (2018): 75–79. http://dx.doi.org/10.1177/1352458517737371.

Full text
Abstract:
A broad scientific consensus has emerged linking multiple sclerosis (MS) risk to multiple independent and interacting DNA variants that are relatively frequent in the population and act in concert with environmental exposures. The multifactorial, polygenic model of heritability provided the rationale and impetus to pursue genome-wide association studies (GWAS), which have been highly successful in uncovering genetic variants influencing susceptibility. Over 200 loci have been firmly associated with MS susceptibility. The main association signal genome-wide maps to the major histocompatibility
APA, Harvard, Vancouver, ISO, and other styles
10

Albatineh, Ahmed N., Raed Alroughani, and Rabeah Al-Temaimi. "Predictors of Multiple Sclerosis Severity Score in Patients with Multiple Sclerosis." International Journal of MS Care 22, no. 5 (2020): 233–38. http://dx.doi.org/10.7224/1537-2073.2019-054.

Full text
Abstract:
Abstract Background: Multiple sclerosis (MS) is a demyelinating autoimmune disorder. Several factors have been shown to associate with MS clinical severity. The influence of different lifestyle factors on MS clinical severity as assessed by the Multiple Sclerosis Severity Score (MSSS) was investigated. Methods: A questionnaire was administered to 128 Kuwaiti MS patients to assess the association of smoking, nutritional supplement use, food allergy, physical activity (PA), and educational level with MSSS. A multiple linear regression model was used to test for associations. Regression model res
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "MS – Multiple Sclerosis"

1

Foley, Peter Leonard. "Pain in multiple sclerosis." Thesis, University of Edinburgh, 2017. http://hdl.handle.net/1842/28949.

Full text
Abstract:
Background: Pain is frequently reported by people with multiple sclerosis (MS). It has been associated with decreased quality of life, psychiatric morbidity, interference with day to day activities, and frequent healthcare attendance. It has been reported by people with multiple sclerosis to be one of their most important symptoms, and available treatments are limited in their effectiveness. Despite this, our understanding of the epidemiology and mechanisms of pain in people with MS are limited. Our understanding of the interactions of central nervous system mechanisms and pain states overall
APA, Harvard, Vancouver, ISO, and other styles
2

Craig, Charles J. "Studies of immunoregulation in Multiple Sclerosis." Thesis, Queen's University Belfast, 1986. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.328088.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Evangelou, N. "Approaches to defining axonal loss in multiple sclerosis." Thesis, University of Oxford, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.249538.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Thannhauser, Jennifer, and University of Lethbridge Faculty of Education. "The psychosocial experiences of individuals diagnosed with early-onset MS." Thesis, Lethbridge, Alta. : University of Lethbridge, Faculty of Education, 2005, 2005. http://hdl.handle.net/10133/284.

Full text
Abstract:
This qualitative study explored the psychosocial experiences of children and adolescents with early-onset multiple sclerosis. In particular, an emphasis was placed on examing peer relationships and social behaviours in relation to these experiences. MS is a chronic neurological disease primarily affecting young adults. However, a proportion of MS patients have onset during childhood and adolescence. Very little is know about the psychosocial impact of MS on these children and adolescents. In particular, youth with MS may be at risk for negative peer experiences due to their chronic illness. Pr
APA, Harvard, Vancouver, ISO, and other styles
5

Brown, Nolan J. "Localization of hemoglobin in MS cortex and its relevance to MS neuropathology." Kent State University Honors College / OhioLINK, 2014. http://rave.ohiolink.edu/etdc/view?acc_num=ksuhonors1399400834.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Rogers, Stephen. "Glycosylation of immunoglobulin G in cerebrospinal fluid and multiple sclerosis." Thesis, University of Surrey, 2001. http://epubs.surrey.ac.uk/843781/.

Full text
Abstract:
The glycosylation features of CSF oligoclonal IgG, and possible changes in N-glycans of CSF IgG in multiple sclerosis (MS) were studied. After isoelectric focusing (IEF) of CSF, bands were detected using biotinylated lectins and avidin-horseradish peroxidase. Concanavalin A (Con A) binding showed that mannose exists throughout the pH range of oligoclonal IgG. Sambucus nigra antigen (SNA) bound acidic and neutral oligoclonal IgG only, suggesting that alkaline oligoclonal IgG is deficient in sialic acid. Deglycosylation of CSF IgG using peptide-N-glycosidase F suggested that the range of isoelec
APA, Harvard, Vancouver, ISO, and other styles
7

Iacobaeus, Ellen. "Establishment and applications of a multiple sclerosis biobank analysis of biomarkers and therapeutic complications in MS /." Stockholm, 2010. http://diss.kib.ki.se/2010/978-91-7409-811-2/.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Mann, C. L. A. "The relationship of genetic polymorphisms to disease severity of multiple sclerosis." Thesis, Keele University, 2000. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.341244.

Full text
Abstract:
The glutathione S-transferase (GST) supergene family encodes isoenzymes that appear to be critical in protection against oxidative stress. Certain GST loci are polymorphic, demonstrating alleles that are null (GSTMI/GSTT1), encode low activity variants (GSTPI), or are associated with variable inducibility (GSTM3). Interleukin-1 (IL- 1) alpha and beta are cytokines involved in recruitment of inflammatory cells, the process of inflammation, and blood-brain barrier breakdown and nerve regeneration. Polymorphisms of both GST and of a complementary interleukin-1 receptor antagonist have been associ
APA, Harvard, Vancouver, ISO, and other styles
9

Thummala, Suneel K. "Axon Initial Segment Stability in Multiple Sclerosis." VCU Scholars Compass, 2015. http://scholarscompass.vcu.edu/etd/4038.

Full text
Abstract:
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system characterized by inflammation and demyelination. In addition to these hallmark features, MS also presents with axonal pathology, which is likely responsible for the signs and symptoms of the disease. Although prominent in MS, axonal pathology is frequently considered a consequence of demyelination and not a primary event. This conclusion is consistent with demyelination inducing the loss of specific axonal domains, known as the nodes of Ranvier that are responsible for the propagation of action potentials along the
APA, Harvard, Vancouver, ISO, and other styles
10

Raask, Pontus, and Oskar Salomonsson. "Att leva med MS : En studie av självbiografier." Thesis, University of Skövde, School of Life Sciences, 2008. http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-1080.

Full text
Abstract:
<p>Att bli diagnostiserad med en kronisk sjukdom som Multipel Skleros (MS) kan vara förödande både fysiskt och psykiskt. Det beror mycket på hur personen med MS hanterar sin nya situation. Studier visar att det finns många sätt att hantera sjukdomen på. Detta kan sammanfattas som copingfaktorer. Syftet med denna studie var att, baserat på självbiografier, beskriva utmärkande copingfaktorer hos personer med Multipel Skleros. Studien har en kvalitativ ansats och åtta självbiografier lästes och analyserades. Resultatet visar att personer hanterar sin sjukdom på många olika sätt. Utmärkande coping
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "MS – Multiple Sclerosis"

1

Jones, Christian. MS: My story. Artshare South West (Cornwall) in conjunction with The Multiple Sclerosis Society of Great Britain and Northern Ireland (Mid-Cornwall Branch), 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Harrold, Kimberly. Sometimes MS is yucky. Science & Humanities Press, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

McLaughlin, Chris. Multiple sclerosis: A positive approach to living with MS. Bloomsbury, 1997.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

T, Fraser Robert, ed. The MS workbook: Living fully with multiple sclerosis. New Harbinger Publications, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Devine, Monique. How to talk about ms with your children: A guide for parents. Multiple Sclerosis Society of Ireland, 2003.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Eerdekens, Jeanine. Chronische ziekte en rolverandering: Een sociologisch onderzoek bij MS-patiënten. Acco, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sahraian, M. A. (Mohammad Ali) and SpringerLink (Online service), eds. MRI Atlas of MS Lesions. Springer-Verlag, 2008.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Romberg, Anders. MS ja liikunta: Iloa, elämänlaatua, toimintakykyä. Edita, 2005.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

1962-, Russell Margot, ed. When the road turns: Inspirational stories about people with MS. Health Communications, 2001.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Reed, Sue. Journey of a soul: In an MS body. Adams Press, 1990.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "MS – Multiple Sclerosis"

1

’t Hart, Bert A., S. Anwar Jagessar, Krista Haanstra, Yolanda S. Kap, and Jon D. Laman. "Modeling MS in Nonhuman Primates." In Multiple Sclerosis Immunology. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7953-6_14.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gawlik, Barbara B., and David A. Hafler. "Regulatory T Cells in MS." In Multiple Sclerosis Immunology. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7953-6_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Friedrich, Anke. "MS and Vaccinations." In The Multiple Sclerosis Companion. Springer Berlin Heidelberg, 2023. http://dx.doi.org/10.1007/978-3-662-67540-3_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Friedrich, Anke. "Forest Fire MS." In The Multiple Sclerosis Companion. Springer Berlin Heidelberg, 2023. http://dx.doi.org/10.1007/978-3-662-67540-3_15.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Freeman, Jennifer. "Rehabilitation in People with Progressive MS." In Progressive Multiple Sclerosis. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65921-3_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Friedrich, Anke. "How MS Is Treated." In The Multiple Sclerosis Companion. Springer Berlin Heidelberg, 2023. http://dx.doi.org/10.1007/978-3-662-67540-3_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Bull, Paul J. "The Impact of MS." In People with Multiple Sclerosis. Palgrave Macmillan UK, 2015. http://dx.doi.org/10.1057/9781137457066_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Abrahamsson, Sofia, Miriam Mattoscio, and Paolo A. Muraro. "Haematopoietic Stem Cells for the Treatment of MS." In Multiple Sclerosis Immunology. Springer New York, 2013. http://dx.doi.org/10.1007/978-1-4614-7953-6_19.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Hutchinson, Michael, and David P. J. Hunt. "Trials of Licenced RRMS DMTs in Progressive MS." In Progressive Multiple Sclerosis. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65921-3_8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Nicholas, R. S., A. Nandoskar, M. Hutchinson, and T. Friede. "Trials of Novel Therapies Specifically for Progressive MS." In Progressive Multiple Sclerosis. Springer International Publishing, 2017. http://dx.doi.org/10.1007/978-3-319-65921-3_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "MS – Multiple Sclerosis"

1

Sharabas, Youssef Hazem Mohamed Fathi, Yasmine Abou Ouf Hamed, and Zeinab Abd El Haliem Taha. "Multiple Sclerosis (MS) Classification and Detection." In 2024 Intelligent Methods, Systems, and Applications (IMSA). IEEE, 2024. http://dx.doi.org/10.1109/imsa61967.2024.10652740.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Mendanha, Serena, Keerthi Reddy Gudibandi, Koduru Hajarathaiah, Bharat Reddy Gudibandi, and Murali Krishna Enduri. "Comparative Analysis of Machine Learning Algorithm; for Conversion Predictors of Clinically Isolated Syndrome (CIS) to Multiple Sclerosis (MS)." In 2025 4th International Conference on Sentiment Analysis and Deep Learning (ICSADL). IEEE, 2025. https://doi.org/10.1109/icsadl65848.2025.10933208.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Guerrera, Brittany, Samantha Farrow, Gloria Zeng, and Sally F. Shady. "Multiple Sclerosis Symptom Analyzer." In ASME 2016 International Mechanical Engineering Congress and Exposition. American Society of Mechanical Engineers, 2016. http://dx.doi.org/10.1115/imece2016-66217.

Full text
Abstract:
Multiple Sclerosis (MS) is a chronic neurodegenerative disease of the central nervous system. MS is typically diagnosed between the ages of 20 and 40. There is no known cause of the disease and each individual experiences varying signs and symptoms depending on the severity of their disease. The most common symptoms include tremor, debilitated gait, visual impairment, or cognitive and emotional disturbances. Current methods used to treat MS include oral medication and surgical treatment. The issues with oral medication are the unwanted side effects to otherwise healthy tissue and the lack of p
APA, Harvard, Vancouver, ISO, and other styles
4

Silva, Diógenes Emanuel Dantas da, Leandro Cabral Moreira Guimarães, Maria Eduarda Medeiros Martins, et al. "Clinical aspects of multiple sclerosis in childhood." In XIV Congresso Paulista de Neurologia. Zeppelini Editorial e Comunicação, 2023. http://dx.doi.org/10.5327/1516-3180.141s1.642.

Full text
Abstract:
Introduction: Multiple sclerosis (MS) is an autoimmune, demyelinating, and inflammatory disease affecting the central nervous system. This condition has an unknown etiology and variable prevalence, being more common in young adult females. The prevalence of MS in childhood is low, ranging from 2% to 4% of all cases. Objectives: This study aims to describe the clinical development and symptoms of MS in children, contrasting them with the development of MS in adults. Dessign: This is an integrative literature review. Methods: Ten articles were selected from the PubMed and SciELO in English and P
APA, Harvard, Vancouver, ISO, and other styles
5

Kaminska, M., DA Trojan, D. Da Costa, et al. "Sleep-Disordered Breathing (SDB) and Fatigue in Multiple Sclerosis (MS)." In American Thoracic Society 2009 International Conference, May 15-20, 2009 • San Diego, California. American Thoracic Society, 2009. http://dx.doi.org/10.1164/ajrccm-conference.2009.179.1_meetingabstracts.a2128.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Morrison, Cecily, Robert Corish, and Abigail Sellen. "ASSESS MS: Supporting the Clinical Assessment of Multiple Sclerosis using Kinect." In 8th International Conference on Pervasive Computing Technologies for Healthcare. ICST, 2014. http://dx.doi.org/10.4108/icst.pervasivehealth.2014.255429.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Brussell, Edward M., and Mike Dixon. "Spatial and Temporal Deficits in Multiple Sclerosis." In Noninvasive Assessment of the Visual System. Optica Publishing Group, 1987. http://dx.doi.org/10.1364/navs.1987.wb4.

Full text
Abstract:
It is new well documented that an attenuation of spatial contrast sensitivity is to be expected in most multiple sclerosis (MS) patients (1-3). Further, it has been reported that patients contrast sensitivity functions can be influenced by modulating the grating in time as well as in space (4-7). The specific consequences of using flickering gratings, however, has been a matter of some conjecture. For example, Marx et al. (5) concluded that temporally modulating stimulus gratings causes a uniform reduction in contrast sensitivity across all spatial frequencies, while Medjbeur and Tulunay-Keese
APA, Harvard, Vancouver, ISO, and other styles
8

Ekgi, Ziya, Muhammed Emin Ozean, Ayse Aralasmak, Emre Dandil, and Murat Cakiroglu. "Automatic computer-aided detection of Multiple Sclerosis (MS) lesions on MR images." In 2015 19th National Biomedical Engineering Meeting (BIYOMUT). IEEE, 2015. http://dx.doi.org/10.1109/biyomut.2015.7369443.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Zhong, Yi, Shouliang Qi, Yan Kang, David Utriainen, Wei Feng, and E. Mark Haacke. "The average cerebral perfusion in patients with multiple sclerosis (MS) using MRI." In 2012 International Conference on Information and Automation (ICIA). IEEE, 2012. http://dx.doi.org/10.1109/icinfa.2012.6246865.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Benjamin, Jacobs, Waddingham Ed, Craner Matt, et al. "OPTIMISE-MS: real-world safety of disease-modifying therapies for multiple sclerosis." In Association of British Neurologists: Annual Meeting Abstracts 2023. BMJ Publishing Group Ltd, 2023. http://dx.doi.org/10.1136/jnnp-2023-abn.100.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "MS – Multiple Sclerosis"

1

Timm, Eliane, Julia Vieregg, and Ursula Wolf. Movement based mindfulness therapies in patients with multiple sclerosis – a systematic review protocol. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.2.0102.

Full text
Abstract:
Review question / Objective: The aim is to review the clinical benefits of mindful moving techniques for persons with multiple sclerosis. Condition being studied: Multiple sclerosis. Multiple sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system (Gholamzad et al., 2019; Oh, Vidal-Jordana, &amp; Montalban, 2018). It has shown to be increasing since 2013, and as of 2020 the estimated number of people with MS is 2.8 million worldwide (Walton et al., 2020). Due accumulation of relapses or gradual progression, disability from MS is worsening over time (Cameron &amp; Ni
APA, Harvard, Vancouver, ISO, and other styles
2

Mahmoudi, Farhad, Mahtab Mokarram, Sadegh Sabouhi, Sara Hashemi, Parastoo Saberi, and Hadi Zamanian. Application of digital health for improving medication adherence in MS patients. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2021. http://dx.doi.org/10.37766/inplasy2021.10.0058.

Full text
Abstract:
Review question / Objective: The aim of this study is to evaluate the efficacy of digital health interventions in monitoring and improving medication adherence in Multiple Sclerosis patients. Condition being studied: Multiple sclerosis (MS) is the most prevalent chronic inflammatory disease of the central nervous system (CNS), which leads to focal lesions in the white matter, characterized by selective primary demyelination with partial preservation of axons and reactive astrocytic gliosis. The disease is thought to be due to a complex interaction between different genetic and environmental fa
APA, Harvard, Vancouver, ISO, and other styles
3

zhang, linlin, xihua liu, yuxiao chen, et al. Effect of exercise training in multiple sclerosis: a protocol for systematic reviews and meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, 2022. http://dx.doi.org/10.37766/inplasy2022.3.0163.

Full text
Abstract:
Review question / Objective: The main purpose of this scheme is to analyze and evaluate the effect on MS symptoms, quality of life, and improvement of mental state through strict literature aerobic training and the movement of resistance training, and to compare aerobic training, resistance training, and the combination of aerobic and resistance training through network meta-analysis, select the best scheme of intervention, and provide a reference for clinical and evidence-based guidelines. Information sources: Randomized controlled trials of exercise therapy for MS were searched in the PubMed
APA, Harvard, Vancouver, ISO, and other styles
4

Nourbakhsh, Bardia, Nisha Revirajan, Bridget Morris, et al. Comparing Medicines to Help Patients with Multiple Sclerosis Feel Less Fatigued -- The TRIUMPHANT-MS Study. Patient-Centered Outcomes Research Institute (PCORI), 2021. http://dx.doi.org/10.25302/06.2021.ms.151133689.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Ehde, Dawn, Kevin Alschuler, Mark Sullivan, et al. Does a Collaborative Care Program for Patients with Multiple Sclerosis Reduce Pain and Depression?—MS Care. Patient-Centered Outcomes Research Institute® (PCORI), 2020. http://dx.doi.org/10.25302/06.2020.ih.13046379.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Ehde, Dawn, Kevin Alschuler, Mark Sullivan, et al. Does a Collaborative Care Program for Patients With Multiple Sclerosis Reduce Pain and Depression?—MS CARE. Patient-Centered Outcomes Research Institute (PCORI), 2020. http://dx.doi.org/10.25302/04.2020.ih.13046379.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Sriram, Subramaniam. MALDI/Mass Spectrometry of Normal Appearing and Dystrophic Axons in Spinal Cord of Multiple Sclerosis (MS). Defense Technical Information Center, 2012. http://dx.doi.org/10.21236/ada582356.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Sriram, Subramaniam. MALDI/Mass Spectrometry of Normal Appearing" and Dystrophic Axons in Spinal Cord of Multiple Sclerosis (MS)". Defense Technical Information Center, 2013. http://dx.doi.org/10.21236/ada592436.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Piehl, Fredick, Anna Fogdell-Hahn, Jessica Smith, et al. Comparing the Safety and Effectiveness of Different Medicines to Treat Multiple Sclerosis – The COMBAT-MS Study. Patient-Centered Outcomes Research Institute (PCORI), 2023. http://dx.doi.org/10.25302/11.2023.ms.151133196.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Braley, Tiffany, and Anna Kratz. Comparing the Effectiveness of Three Treatments for Reducing Fatigue among Patients with Multiple Sclerosis -- The COMBO-MS Trial. Patient-Centered Outcomes Research Institute (PCORI), 2023. http://dx.doi.org/10.25302/10.2023.ms.161036980.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'MS – Multiple Sclerosis' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography